Position in DXCM
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$2,104,867
-$136,978 QoQ
Shares Held
33,517
-0.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Taylor Frigon Capital Management LLC holds $14,232,882 across 8 Medical Devices names. DXCM ranks #3 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GKOS |
GLAUKOS Corp
|
23,445 | $2,524,088 | |
| 2 | PRCT |
PROCEPT BioRobotics Corp
|
88,708 | $2,218,587 | |
| 3 | DXCM |
Dexcom Inc
This page
|
33,517 | $2,104,867 | |
| 4 | TMDX |
TransMedics Group, Inc.
|
19,718 | $1,960,166 | |
| 5 | APYX |
Apyx Medical Corp
|
414,559 | $1,529,722 | |
| 6 | STE |
STERIS plc
|
6,378 | $1,410,367 | |
| 7 | SYK |
Stryker Corp
|
3,910 | $1,284,786 | |
| 8 | CLPT |
ClearPoint Neuro, Inc.
|
131,901 | $1,200,299 |
All Filings in DXCM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,104,867 | 33,517 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,241,845 | 33,778 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,738,840 | 25,841 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,336,666 | 26,769 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,943,943 | 28,466 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $2,259,996 | 29,060 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,182,420 | 32,554 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $2,435,289 | 21,479 | Shares | Sole | 2024-07-29 | |
| No filing history on record for this holder in this stock. | ||||||